Tradestie Institutional Equity Comparison Engine
FEMY vs ZJYL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ZJYL Overall Edge
ZJYL Captures Institutional Edge (3โ0 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, FEMY trades at N/M Forward P/E with -763.9% operating margin (-18.9% YoY revenue) versus ZJYL at N/M Forward P/E and 2.1% operating margin (-9.7% YoY). In options structure, FEMY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ZJYL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
ZJYL
FEMY N/M vs ZJYL N/M Fwd P/E
Growth & Margin Winner
ZJYL
Op Margin -763.9% vs 2.1% ยท YoY -18.9% vs -9.7%
Momentum & Technical Winner
ZJYL
1Y +54.8% vs +1264.7% ยท 52W Pos 17% vs 73%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
FEMY
NASDAQ
Femasys Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.28
-9.86% 1D
Market Cap
$11.9M
1M Return
-22.42%
1Y Return
+54.78%
Forward P/E
N/M
Unified AI Score
52.6 / 100
HOLD
Tech 61.0
Fund 62.0
Flow 50.0
Mom 64.0
ZJYL
NASDAQ
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$3.63
+3.71% 1D
Market Cap
$557.2M
1M Return
+74.51%
1Y Return
+1264.66%
Forward P/E
N/M
Unified AI Score
33.1 / 100
SELL
Tech 50.0
Fund 31.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
FEMY +54.78%
ZJYL +1264.66%
Spread: +1241.37 pp (ZJYL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
FEMY TTM Op. Margin: -763.9%
ZJYL TTM Op. Margin: 2.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FEMY vs ZJYL. Trailing 12-month operating profitability (FEMY -763.9% vs ZJYL 2.1%) and valuation multiples (FEMY N/M vs ZJYL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FEMY | ZJYL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $11.9M | $557.2M | Larger Scale | ZJYL |
| Trailing P/E Ratio Valuation | N/M | 18.4x | Lower Multiple | ZJYL |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -18.9% | -9.7% | Higher Growth | ZJYL |
| Operating Margin (TTM) Profitability | -763.9% | 2.1% | Higher Margin | ZJYL |
| Net Profit Margin Profitability | 0.0% | 5.9% | Higher Margin | ZJYL |
| Return on Equity (ROE) Capital Efficiency | -425.0% | 4.0% | Higher ROE | ZJYL |
| 52-Week Range Position Momentum | 17% ($0โ$6) | 73% ($0โ$5) | Stronger Trend | ZJYL |
| Beta / 30D Volatility Risk Regime | 4.01ฮฒ ยท 72% Vol | 14.10ฮฒ ยท 180% Vol | Lower Realized Risk | FEMY |
| Unified Institutional Score Composite Signal | 52.6 / 100 (HOLD) | 33.1 / 100 (SELL) | Higher Composite | FEMY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full FEMY vs ZJYL Buy Guide
FEMY
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ZJYL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither FEMY nor ZJYL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.